T. Scott Johnson
Fondateur chez JSB-Partners LP
Profil
T.
Scott Johnson is the founder of The Medicines Co. (founded in 1996) and JSB-Partners LP (founded in 1999).
He held the title of Chief Medical Advisor & VP-New Business Ventures at The Medicines Co. from 2011 to 2012.
He is currently the Chairman of MaxiVAX SA and a Director at Atalanta Therapeutics, Inc. Dr. Johnson previously worked as a Director at Vero Biotech LLC and as a Managing Director at MPM BioImpact, Inc. from 1991 to 1999.
He received his undergraduate and doctorate degrees from The University of Alabama.
Postes actifs de T. Scott Johnson
| Sociétés | Poste | Début |
|---|---|---|
JSB-Partners LP
 JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Fondateur | 23/07/2009 |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Directeur/Membre du Conseil | - |
MaxiVAX SA
 MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Président | - |
Anciens postes connus de T. Scott Johnson
| Sociétés | Poste | Fin |
|---|---|---|
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 01/07/1999 |
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | - |
| THE MEDICINES COMPANY | Fondateur | - |
Formation de T. Scott Johnson
| The University of Alabama | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
JSB-Partners LP
JSB-Partners LP Investment Banks/BrokersFinance JSB-Partners LP offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. Its services include product partnerships, mergers and acquisitions, private placements and public underwritings. The company was founded by Wolfgang Rudolph Ralph Stoiber in 1999 and is headquartered in Boston, MA. | Finance |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
MaxiVAX SA
MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Commercial Services |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
